Clinical Trials Advisory Committee
The primary purpose of the Clinical Trials Advisory Committee (CTAC) is to advise the Oversight Committee on important issues of the clinical trials. The CTAC shall give their expert opinion on the impact of current CPRIT mechanisms supporting clinical trials; give advice on opportunities to increase CPRIT’s impact on translating basic discoveries to clinical trials; and advise on mechanisms that would address barriers to patient enrollment in therapeutic clinical trials.
Related Documents:
Clinical Trials Advisory Committee Annual Report for Fiscal Year 2024Clinical Trials Advisory Committee Annual Report for Fiscal Year 2023
|
Thomas E. Hutson, DO, PharmD, Ph.D., Chair Texas Oncology-Abilene/West Texas
|
|
Suzanne Cole, M.D., FACP, FASCO, Vice-Chair Hematologist & Medical Oncologist
Medical Director, Community Oncology Program at the UT Southwestern Simmons Comprehensive Cancer Center
Leader of Cancer Research, Community Oncology Program
Assistant Professor, Division of Hematology, and Oncology
UT Southwestern Medical Center
|
|
April Bell, M.S., CCRC, ACRP, ACRP-PM Manager, Clinical Research Operations
JPS Health Network
|
|
Ruma Bhagat M.D., MPH Principal Science Leader
Genentech, Inc. (A Member of the Roche Group)
|
|
Everardo Cobos, M.D., FACP Chair, Department of Medicine and Oncology
University of Texas Rio Grande Valley, School of Medicine
|
|
Suzanne Cole, M.D., FACP, FASCO Hematologist & Medical Oncologist
Medical Director, Community Oncology Program at the UT Southwestern Simmons Comprehensive Cancer Center
Leader of Cancer Research, Community Oncology Program
Assistant Professor, Division of Hematology, and Oncology
UT Southwestern Medical Center
|
|
S. Gail Eckhardt, M.D., FASCO Associate Dean of Experimental Therapeutics
Associate Director for Translational Research
Dan L. Duncan Comprehensive Cancer Center
|
|
David S. Hong M.D. Deputy Chair of the Department of Investigational Cancer Therapeutics
Clinical Medical Director of the Clinical Center for Targeted Therapy (CCTT)
Associate Vice President of Clinical Research
University of Texas M.D. Anderson Cancer Center
|
|
Ronan J. Kelly M.D., MBA Director of the Charles A. Sammons Cancer Center, Baylor University Medical Center
Chief of Oncology Baylor Scott & White (NTx)
Clinical Professor, Texas A&M University College of Medicine
Adjunct Associate Professor of Oncology, Johns Hopkins
|
|
Martha P. Mims, M.D., Ph.D. Professor of Medicine
Section Chief, Hematology/Oncology
Baylor College of Medicine
|
|
Pavan Reddy, M.D. Director
Senior Associate Dean, Cancer Programs
Professor
Baylor College of Medicine
|
|
C Patrick Reynolds, M.D., Ph.D. Director, Cancer Center
Professor, Department of Pediatrics
Texas Tech University Health Sciences Center
|
|
Jeff Yorio, M.D. Hematologist-Oncologist
Central & South Texas Site Research Leader
Chief of Hematology-Oncology
Texas Oncology-Austin Central
Sarah Cannon Research Institute at Texas Oncology
Ascension Seton Medical Center Austin
|